Table 6.

Combined GEP 70-gene and sIL6r-risk groups annotated with 1q21 vCA, rs2228145 genotype, and sIL-6r concentration (N = 626)

	Low-risk GEP/low sIL-6r (n = 451)	Low-risk GEP/high sIL-6r (n = 94)	High-risk GEP/low sIL-r (n = 46)	High-risk GEP/high sIL-6r (n = 35)
% with 1q21 Amp	26.8	59.6	58.7	94.3
Average sIL-6r, ng/mL	48.3	115.8	51.6	142.5
% AA	39.7	10.6	45.7	28.6
% of AA with Amp	31.2	70.0	85.7	100
AA NL average sIL-6r, ng/mL	37.2	106.4	32.2	NA
AA Amp average sIL-6r, ng/mL	43.7	102.5	50.4	122.1
% AC	47.7	51.1	47.8	40.0
% of AC with Amp	25.1	62.5	36.4	85.7
AC NL average sIL-6r, ng/mL	50.7	116.1	53.9	97.8
AC Amp average sIL-6r, ng/mL	55.6	119.3	54.2	144.9
% CC	12.6	38.3	6.5	31.4
% of CC with Amp	19.3	52.8	33.3	100
CC NL average sIL-6r, ng/mL	62.5	102.7	63.5	NA
CC Amp average sIL-6r, ng/mL	64.8	128.6	51.7	166.6

NA indicates not applicable.